Case File
efta-02141608DOJ Data Set 10OtherEFTA02141608
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02141608
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Rosa da Siiv
From:
Sent
Mon 4/22/2013 6:39:14 PM
Subject: Re: Jeffrey Epstein
you bet!
On Apr 22, 2013, at 2:38 PM, Rosa da Silva wrote:
Thank you.
From:
Sent: Monday, April 22, 2013 1:47 PM
To: Rosa da Silva
Subject: Re: Jeffrey Epstein
Rosa, Jeffrey gave me the below:
On Apr 22, 2013, at 1:32 PM, Rosa da Silva wrote:
OK. How do we contact Ehud? Thanks, Rosa
From
Sent: Monday, April 22, 2013 1:31 PM
To: Rosa da Silva
Subject: Jeffrey Epstein
Hey Rosa...Jeffrey says to just let Jes and Ehud coordinate directly...
ok?
This e-mail is intended only for the person or entity to which it is addressed and may
contain confidential and/or privileged material. Any review, retransmission,
dissemination or other use of, or taking of any action in reliance upon, the
information in this e-mail by persons or entities other than the intended recipient is
prohibited and may be unlawful. If you received this in error, please contact the
sender and delete the material from any computer.
This communication is for informational purposes only. It is not intended as and does not
constitute an offer or solicitation for the purchase or sale of any financial
EFTA_R1_00796208
EFTA02141608
instrument or as an official confirmation of any transaction. All market prices, data
and other information are not warranted as to completeness or accuracy and are
subject to change without notice. Any expected returns are provided for
illustrative purposes only and are not intended to serve as, and must not be relied
upon by any prospective investor as, a guaranty, an assurance, a prediction of a
definitive statement of fact or a probability. Investment in funds managed by
BlueMountain carries certain risks, including the risk of loss of principal. Unless
indicated otherwise, performance results are presented net of fees and expenses.
Certain market and economic events having an impact on performance may not
repeat themselves. Any comments or statements made herein do not necessarily
reflect those of BlueMountain Capital Management, LLC or its affiliates. PAST
PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE
RESULTS AND NO REPRESENTATION IS MADE THAT RESULTS
SIMILAR TO THOSE SHOWN CAN BE ACHIEVED.
This e-mail is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material.
My review. retransmission. dissemination or other use of. or taking of any action in reliance upon, the information in this e-
mail by parsecs or entities other than the intended recipient is prohibited and may be unlawful. If you received this in error.
please contact the sender and delete the material from any computer.
This communication is for informational purposes only. It is not intended as and does not constitute an offer or solicitation for the
purchase or sale of any financial instrument or as an official confirmation of any transaction. MI market prices. data and
other information are not warranted as to completeness or accuracy and aro subject to change without notice. Any
expected returns are provided for illustrative purposes only and are not intended to serve as. and must not be relied upon
by any prospective investor as. a guaranty. an assurance. a prediction of a definitive statement of fact or a probability.
Investment in funds managed by BlueMountain crones certain risks. including the risk of loss of principal. Unless indicated
otherwise. performance results are presented net of fees and expenses. Certain market and economic events having an
impact on performance may not repeat themselves. Any comments or statements made herein do not necessarily reflect
those of BlueMountain Capital Management. LLC or its affiliates. PAST PERFORMANCE IS NOT NECESSARILY
INDICATIVE OF FUTURE RESULTS AND NO REPRESENTATION IS MADE THAT RESULTS SIMILAR TO THOSE
SHOWN CAN BE ACHIEVED.
EFTA_R1_00796209
EFTA02141609
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2141608Phone
2141609Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.